SpinewayFRA:37S -0.86%45 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates FRA:37S with a GF Score™ of 45/100 and a GF Value™ of €197.91 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Spineway ranks better than 81.51% on this metric.
The historical rank and industry rank for Spineway's Days Payable or its related term are showing as below:
FRA:37S'
s Days Payable Range Over the Past 10 Years
Min: 127.26 Med: 190.98 Max: 860.36
Current: 173.8
During the past 13 years, Spineway's highest Days Payable was 860.36. The lowest was 127.26. And the median was 190.98.
FRA:37S's Days Payable is ranked better than 81.51% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs FRA:37S: 173.80
Spineway's Days Payable
stayed the same
from Dec. 2024 (0.00) to Dec. 2025 (0.00).
Spineway Days Payable Related Terms
Spineway Days Payable Historical Data
* Premium members only.
The historical data trend for Spineway's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:37S vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Spineway's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spineway Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Spineway's Days Payable distribution charts can be found below:
* The bar in red indicates where Spineway's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Spineway's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spineway (FRA:37S) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Spineway and its competitors. Over the past decade, Spineway's Days Payable has ranged from 127.26 to 860.36. According to the industry distribution chart, Spineway ranks #147 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 18.5%.
Is Spineway's Days Payable too high?
Spineway's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 127.26 to a high of 860.36. Based on the distribution chart, Spineway ranks #147 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Spineway has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Spineway's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Spineway ranks #147 out of 795 companies for Days Payable. This places Spineway in the top 19% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. Historically, Spineway's own Days Payable has ranged from 127.26 to 860.36 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Spineway and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spineway's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spineway stock overvalued right now?
Based on GuruFocus' analysis, Spineway (FRA:37S) is currently considered Possible Value Trap. The stock's GF Value™ is €197.91, compared to a current price of €0.12 — trading 99.9% below its estimated fair value. The current Days Payable is 0.00. Spineway's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Spineway (FRA:37S), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spineway (FRA:37S) Overvalued in 2026?
Based on GuruFocus' analysis, Spineway stock appears to be undervalued.
The current stock price of €0.12 is trading 99.9% below its estimated GF Value™ of €197.91.
GuruFocus considers Spineway to be Possible Value Trap.
Key valuation signals for FRA:37S:
Days Payable: 0.00
GF Value™: €197.91 vs. price of €0.12 (99.9% below fair value)
No single metric tells the full story. See the FRA:37S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spineway designs produce and markets implant lines and ancillary surgical equipment used for the treatment of severe disorders of the spinal column. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, and other such medical instruments.
45GF Score
Get the complete analysis for FRA:37S
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:37S has been successfully added to your 
